News

Prospect of Synthetic Embryos Sparks New Bioethics Debate

(MIT Technology Review) – The embryo-like structures, the team soon determined, are not complete and couldn’t become a person. They lack the cell types needed to make a placenta, a heart, or a brain. Even so, the Michigan “embryoids” are … Read More

Mesenchymal Stem Cells Offer Novel Treatment Approach for Crohn’s Disease Fistula

(Eurekalert) – A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery. A … Read More

CardioBrief: Cardiac Stem Cell Therapies May Get Boost from New FDA

(MedPage Today) – Cardiac stem cell therapy could gain FDA approval far earlier than most people expect, despite the fact that these therapies have consistently failed to produce any convincing evidence of safety and efficacy. Under the old FDA rules … Read More

Antibody-Created Stem Cells May Have Superior Properties

(The San Diego Union-Tribune) – A new way to make a promising kind of stem cell has been developed by scientists at The Scripps Research Institute, an advance that might eventually improve the quality of these cells. Scientists led by … Read More

South Korean Researchers Lobby Government to Lift Human-Embryo Restrictions

(Nature) – More than a decade after a fraud scandal in stem-cell science rocked South Korea, scientists in the field are ramping up pressure on the government to relax the country’s strict regulations on human-embryo research — which many researchers … Read More

New Articles for Science as Culture Are Now Available

Science as Culture (online first, 2017) has new articles available online by subscription only. Articles Include: “Research Misconduct in the Age of Open Science: The Case of STAP Stem Cells” by Mianna Meskus, Luca Marelli, and Giuseppe D’Agostino

Researchers Build First Functional Vascularized Lung Scaffold

(UPI) – Researchers at Columbia University have become the first to successfully bioengineer a functional vascularized lung scaffold to treat disease. The scaffold allows the removal of the pulmonary epithelium while maintaining the viability and function of the vascular network … Read More

RSS from Bioethics.com

{
Adult/73
|
Embryonic/0
}